🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/06/2007 | 50,11 | 50,48 | 49,50 | 49,75 | -0,59% | 1,94% | 11.650.616 |
| 31/05/2007 | 50,21 | 50,74 | 50,05 | 50,05 | -0,49% | 1,39% | 11.751.958 |
| 30/05/2007 | 50,72 | 50,72 | 49,58 | 50,30 | -1,29% | 2,24% | 15.706.166 |
| 29/05/2007 | 51,36 | 51,54 | 50,57 | 50,95 | -0,56% | 1,88% | 10.423.513 |
| 25/05/2007 | 51,23 | 51,29 | 51,03 | 51,24 | -0,09% | 0,50% | 13.246.510 |
| 24/05/2007 | 51,43 | 52,09 | 50,79 | 51,29 | -1,10% | 2,52% | 10.597.271 |
| 23/05/2007 | 51,89 | 52,19 | 51,62 | 51,86 | +0,37% | 1,10% | 10.507.353 |
| 22/05/2007 | 51,62 | 52,61 | 51,53 | 51,67 | +0,67% | 2,11% | 15.245.256 |
| 21/05/2007 | 50,60 | 52,19 | 50,57 | 51,33 | +1,01% | 3,19% | 20.620.134 |
| 18/05/2007 | 50,15 | 50,81 | 49,86 | 50,81 | +1,51% | 1,90% | 14.401.092 |
| 17/05/2007 | 50,28 | 50,55 | 49,93 | 50,06 | -0,44% | 1,23% | 9.680.481 |
| 16/05/2007 | 50,57 | 50,57 | 49,76 | 50,28 | +0,13% | 1,60% | 11.380.127 |
| 15/05/2007 | 49,68 | 50,27 | 49,60 | 50,21 | +1,04% | 1,34% | 12.289.686 |
| 14/05/2007 | 49,62 | 50,21 | 49,49 | 49,69 | +0,15% | 1,44% | 8.657.947 |
| 11/05/2007 | 48,76 | 49,75 | 48,76 | 49,62 | +1,80% | 2,04% | 10.144.326 |
| 10/05/2007 | 49,30 | 49,49 | 48,66 | 48,74 | -1,86% | 1,68% | 9.791.254 |
| 09/05/2007 | 49,80 | 49,95 | 49,42 | 49,67 | -0,36% | 1,07% | 9.351.199 |
| 08/05/2007 | 49,49 | 49,89 | 49,27 | 49,85 | +0,40% | 1,23% | 8.267.148 |
| 07/05/2007 | 49,48 | 49,68 | 49,43 | 49,65 | +0,21% | 0,50% | 6.984.396 |
| 04/05/2007 | 49,27 | 49,90 | 49,19 | 49,54 | +0,72% | 1,43% | 9.098.107 |
| 03/05/2007 | 49,05 | 49,43 | 48,74 | 49,19 | +0,62% | 1,40% | 8.609.739 |
| 02/05/2007 | 48,95 | 49,14 | 48,77 | 48,88 | +0,49% | 0,76% | 8.261.384 |
| 01/05/2007 | 49,28 | 49,36 | 48,23 | 48,65 | -0,89% | 2,30% | 11.230.682 |
| 30/04/2007 | 49,44 | 49,53 | 48,81 | 49,08 | -0,81% | 1,47% | 10.758.558 |
| 27/04/2007 | 49,87 | 49,96 | 49,18 | 49,48 | -1,09% | 1,57% | 11.739.591 |
| 26/04/2007 | 49,98 | 50,22 | 49,69 | 50,03 | +0,08% | 1,05% | 10.736.970 |
| 25/04/2007 | 49,32 | 50,10 | 49,01 | 49,99 | +1,53% | 2,21% | 12.653.657 |
| 24/04/2007 | 49,28 | 49,87 | 48,67 | 49,24 | -0,14% | 2,42% | 9.350.780 |
| 23/04/2007 | 48,96 | 49,71 | 48,66 | 49,30 | +0,35% | 2,14% | 15.446.158 |
| 20/04/2007 | 48,46 | 49,26 | 48,04 | 49,13 | +2,67% | 2,50% | 19.576.745 |